RYTM FY 2016 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RYTMRhythm Pharmaceuticals, Inc.

$6B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$144,000

Operating Income

-$26M

Net Income

-$26M

EPS (Diluted)

$-1.55

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$24M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$12M

Total Liabilities

$5M

Stockholders' Equity

$7M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$144,000	$0	—
Operating Income	-$26M	-$11M	-145.0%
Net Income	-$26M	-$11M	-133.6%